Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1743-422X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users ; volume:14 ; number:1 ; day:11 ; month:7 ; year:2017 ; pages:1-6 ; date:12.2017
Virology journal ; 14, Heft 1 (11.7.2017), 1-6, 12.2017

Classification: Medizin, Gesundheit

Creator: Jamalidoust, Marzieh

Contributor: Namayandeh, Mandana
Moghadami, Mohsen
Ziyaeyan, Mazyar
SpringerLink (Online service)

DOI: 10.1186/s12985-017-0797-2

URN: urn:nbn:de:1111-2017080912139

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:31 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Jamalidoust, Marzieh
Namayandeh, Mandana
Moghadami, Mohsen
Ziyaeyan, Mazyar
SpringerLink (Online service)

Other Objects (12)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

Graffiti | Streetart

HCV

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b

Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies

Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis

Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders

Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

Graffiti | Streetart

HCV

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b

Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies

Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis

Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders

Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

Graffiti | Streetart

HCV

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b

Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies

Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis

Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders

Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

HCV

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b

Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies

Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis

Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders

Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

HCV

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b

Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies

Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis

Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders

Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

HCV

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b

Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies

Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis

Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders

Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients

Related objects

Reset password